{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,21]],"date-time":"2026-02-21T01:20:16Z","timestamp":1771636816173,"version":"3.50.1"},"reference-count":100,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,5,3]],"date-time":"2025-05-03T00:00:00Z","timestamp":1746230400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,5,3]],"date-time":"2025-05-03T00:00:00Z","timestamp":1746230400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100000054","name":"U.S. Department of Health & Human Services | NIH | National Cancer Institute","doi-asserted-by":"publisher","award":["CA218467"],"award-info":[{"award-number":["CA218467"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000054","name":"U.S. Department of Health & Human Services | NIH | National Cancer Institute","doi-asserted-by":"publisher","award":["CA222064"],"award-info":[{"award-number":["CA222064"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000005","name":"U.S. Department of Defense","doi-asserted-by":"publisher","award":["CA180768-W81XWH1910306"],"award-info":[{"award-number":["CA180768-W81XWH1910306"]}],"id":[{"id":"10.13039\/100000005","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000060","name":"U.S. Department of Health & Human Services | NIH | National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","award":["AI143992"],"award-info":[{"award-number":["AI143992"]}],"id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000048","name":"American Cancer Society","doi-asserted-by":"publisher","award":["RSG-19-025-01-DDC"],"award-info":[{"award-number":["RSG-19-025-01-DDC"]}],"id":[{"id":"10.13039\/100000048","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000057","name":"U.S. Department of Health & Human Services | NIH | National Institute of General Medical Sciences","doi-asserted-by":"publisher","award":["GM008056"],"award-info":[{"award-number":["GM008056"]}],"id":[{"id":"10.13039\/100000057","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000050","name":"U.S. Department of Health & Human Services | NIH | National Heart, Lung, and Blood Institute","doi-asserted-by":"publisher","award":["HL103827"],"award-info":[{"award-number":["HL103827"]}],"id":[{"id":"10.13039\/100000050","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Commun"],"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:p>Addiction to oncogene-rewired transcriptional networks is a therapeutic vulnerability in cancer cells, underscoring a need to better understand mechanisms that relay oncogene signals to the transcriptional machinery. Here, using human and mouse T cell acute lymphoblastic leukemia (T-ALL) models, we identify an essential requirement for the endosomal sorting complex required for transport protein CHMP5 in T-ALL epigenetic and transcriptional programming. CHMP5 is highly expressed in T-ALL cells where it mediates recruitment of the coactivator BRD4 and the histone acetyl transferase p300 to enhancers and super-enhancers that enable transcription of T-ALL genes. Consequently, CHMP5 depletion causes severe downregulation of critical T-ALL genes, mitigates chemoresistance and impairs T-ALL initiation by oncogenic NOTCH1 in vivo. Altogether, our findings uncover a non-oncogene dependency on CHMP5 that enables T-ALL initiation and maintenance.<\/jats:p>","DOI":"10.1038\/s41467-025-59504-9","type":"journal-article","created":{"date-parts":[[2025,5,3]],"date-time":"2025-05-03T14:46:08Z","timestamp":1746283568000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["The ESCRT protein CHMP5 promotes T cell leukemia by enabling BRD4-p300-dependent transcription"],"prefix":"10.1038","volume":"16","author":[{"given":"Katharine","family":"Umphred-Wilson","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shashikala","family":"Ratnayake","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3235-3372","authenticated-orcid":false,"given":"Qianzi","family":"Tang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6842-119X","authenticated-orcid":false,"given":"Rui","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sneha Ghosh","family":"Chaudhary","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Devaiah N.","family":"Ballachanda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Josephine","family":"Trichka","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jan","family":"Wisniewski","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lan","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qingrong","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daoud","family":"Meerzaman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dinah S.","family":"Singer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9092-5960","authenticated-orcid":false,"given":"Stanley","family":"Adoro","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,5,3]]},"reference":[{"key":"59504_CR1","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1126\/science.1073096","volume":"297","author":"IB Weinstein","year":"2002","unstructured":"Weinstein, I. B. Addiction to oncogenes\u2013the achilles heal of cancer. Science 297, 63\u201364 (2002).","journal-title":"Science"},{"key":"59504_CR2","doi-asserted-by":"publisher","first-page":"629","DOI":"10.1016\/j.cell.2016.12.013","volume":"168","author":"JE Bradner","year":"2017","unstructured":"Bradner, J. E., Hnisz, D. & Young, R. A. Transcriptional addiction in cancer. Cell 168, 629\u2013643 (2017).","journal-title":"Cell"},{"key":"59504_CR3","doi-asserted-by":"publisher","first-page":"904","DOI":"10.1016\/j.cell.2011.08.017","volume":"146","author":"JE Delmore","year":"2011","unstructured":"Delmore, J. E. et al. BET bromodomain inhibition as a therapeutic strategy to target c-Myc. Cell 146, 904\u2013917 (2011).","journal-title":"Cell"},{"key":"59504_CR4","doi-asserted-by":"publisher","first-page":"524","DOI":"10.1038\/nature10334","volume":"478","author":"J Zuber","year":"2011","unstructured":"Zuber, J. et al. RNAi screen identifies Brd4 as a therapeutic target in acute myeloid leukaemia. Nature 478, 524\u2013528 (2011).","journal-title":"Nature"},{"key":"59504_CR5","doi-asserted-by":"publisher","first-page":"1040","DOI":"10.1182\/blood-2013-08-522698","volume":"123","author":"JE Roderick","year":"2014","unstructured":"Roderick, J. E. et al. c-Myc inhibition prevents leukemia initiation in mice and impairs the growth of relapsed and induction failure pediatric T-ALL cells. Blood 123, 1040\u20131050 (2014).","journal-title":"Blood"},{"key":"59504_CR6","doi-asserted-by":"publisher","first-page":"e72967","DOI":"10.1371\/journal.pone.0072967","volume":"8","author":"A Wyce","year":"2013","unstructured":"Wyce, A. et al. BET inhibition silences expression of MYCN and BCL2 and induces cytotoxicity in neuroblastoma tumor models. PLoS ONE 8, e72967 (2013).","journal-title":"PLoS ONE"},{"key":"59504_CR7","doi-asserted-by":"publisher","first-page":"540","DOI":"10.1038\/nsmb.3228","volume":"23","author":"BN Devaiah","year":"2016","unstructured":"Devaiah, B. N. et al. BRD4 is a histone acetyltransferase that evicts nucleosomes from chromatin. Nat. Struct. Mol. Biol. 23, 540\u2013548 (2016).","journal-title":"Nat. Struct. Mol. Biol."},{"key":"59504_CR8","doi-asserted-by":"publisher","first-page":"6927","DOI":"10.1073\/pnas.1120422109","volume":"109","author":"BN Devaiah","year":"2012","unstructured":"Devaiah, B. N. et al. BRD4 is an atypical kinase that phosphorylates Serine2 of the RNA Polymerase II carboxy-terminal domain. Proc. Natl Acad. Sci. 109, 6927\u20136932 (2012).","journal-title":"Proc. Natl Acad. Sci."},{"key":"59504_CR9","doi-asserted-by":"publisher","first-page":"1581","DOI":"10.1016\/j.cell.2013.10.056","volume":"155","author":"W Liu","year":"2013","unstructured":"Liu, W. et al. Brd4 and JMJD6-associated anti-pause enhancers in regulation of transcriptional pause release. Cell 155, 1581\u20131595 (2013).","journal-title":"Cell"},{"key":"59504_CR10","doi-asserted-by":"publisher","first-page":"2166","DOI":"10.1016\/j.molcel.2021.03.008","volume":"81","author":"T Narita","year":"2021","unstructured":"Narita, T. et al. Enhancers are activated by p300\/CBP activity-dependent PIC assembly, RNAPII recruitment, and pause release. Mol. Cell 81, 2166\u20132182.e2166 (2021).","journal-title":"Mol. Cell"},{"key":"59504_CR11","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1016\/j.cell.2018.04.033","volume":"174","author":"BT Weinert","year":"2018","unstructured":"Weinert, B. T. et al. Time-Resolved Analysis Reveals Rapid Dynamics and Broad Scope of the CBP\/p300 Acetylome. Cell 174, 231\u2013244.e212 (2018).","journal-title":"Cell"},{"key":"59504_CR12","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1309\/AJCPMF03LVSBLHPJ","volume":"144","author":"MJ You","year":"2015","unstructured":"You, M. J., Medeiros, L. J. & Hsi, E. D. T-Lymphoblastic Leukemia\/Lymphoma. Am. J. Clin. Pathol. 144, 411\u2013422 (2015).","journal-title":"Am. J. Clin. Pathol."},{"key":"59504_CR13","doi-asserted-by":"publisher","first-page":"1552","DOI":"10.1016\/j.cell.2013.05.041","volume":"153","author":"B King","year":"2013","unstructured":"King, B. et al. The ubiquitin ligase FBXW7 modulates leukemia-initiating cell activity by regulating MYC stability. Cell 153, 1552\u20131566 (2013).","journal-title":"Cell"},{"key":"59504_CR14","doi-asserted-by":"publisher","first-page":"1261","DOI":"10.1038\/s41375-022-01516-1","volume":"36","author":"S Piya","year":"2022","unstructured":"Piya, S. et al. Targeting the NOTCH1-MYC-CD44 axis in leukemia-initiating cells in T-ALL. Leukemia 36, 1261\u20131273 (2022).","journal-title":"Leukemia"},{"key":"59504_CR15","doi-asserted-by":"publisher","first-page":"1124","DOI":"10.1182\/blood-2016-09-692582","volume":"129","author":"M Sanchez-Martin","year":"2017","unstructured":"Sanchez-Martin, M. & Ferrando, A. The NOTCH1-MYC highway toward T-cell acute lymphoblastic leukemia. Blood 129, 1124\u20131133 (2017).","journal-title":"Blood"},{"key":"59504_CR16","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1126\/science.1102160","volume":"306","author":"AP Weng","year":"2004","unstructured":"Weng, A. P. et al. Activating mutations of NOTCH1 in human T cell acute lymphoblastic leukemia. Science 306, 269\u2013271 (2004).","journal-title":"Science"},{"key":"59504_CR17","doi-asserted-by":"publisher","first-page":"1130","DOI":"10.1038\/nm.3665","volume":"20","author":"D Herranz","year":"2014","unstructured":"Herranz, D. et al. A NOTCH1-driven MYC enhancer promotes T cell development, transformation and acute lymphoblastic leukemia. Nat. Med. 20, 1130\u20131137 (2014).","journal-title":"Nat. Med."},{"key":"59504_CR18","doi-asserted-by":"publisher","first-page":"E4946","DOI":"10.1073\/pnas.1407079111","volume":"111","author":"Y Yashiro-Ohtani","year":"2014","unstructured":"Yashiro-Ohtani, Y. et al. Long-range enhancer activity determines Myc sensitivity to Notch inhibitors in T cell leukemia. Proc. Natl Acad. Sci. USA 111, E4946\u2013E4953 (2014).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"59504_CR19","doi-asserted-by":"publisher","first-page":"364","DOI":"10.1038\/ng.2913","volume":"46","author":"B Knoechel","year":"2014","unstructured":"Knoechel, B. et al. An epigenetic mechanism of resistance to targeted therapy in T cell acute lymphoblastic leukemia. Nat. Genet. 46, 364\u2013370 (2014).","journal-title":"Nat. Genet."},{"key":"59504_CR20","doi-asserted-by":"publisher","first-page":"543","DOI":"10.1038\/nature14898","volume":"525","author":"P Rathert","year":"2015","unstructured":"Rathert, P. et al. Transcriptional plasticity promotes primary and acquired resistance to BET inhibition. Nature 525, 543\u2013547 (2015).","journal-title":"Nature"},{"key":"59504_CR21","doi-asserted-by":"publisher","first-page":"711","DOI":"10.1091\/mbc.12.3.711","volume":"12","author":"A Kranz","year":"2001","unstructured":"Kranz, A., Kinner, A. & K\u00f6lling, R. A family of small coiled-coil-forming proteins functioning at the late endosome in yeast. Mol. Biol. Cell 12, 711\u2013723 (2001).","journal-title":"Mol. Biol. Cell"},{"key":"59504_CR22","doi-asserted-by":"publisher","first-page":"1267","DOI":"10.1046\/j.1365-2958.2003.03556.x","volume":"49","author":"JR Kohler","year":"2003","unstructured":"Kohler, J. R. Mos10 (Vps60) is required for normal filament maturation in Saccharomyces cerevisiae. Mol. Microbiol. 49, 1267\u20131285 (2003).","journal-title":"Mol. Microbiol."},{"key":"59504_CR23","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1016\/j.devcel.2007.10.021","volume":"14","author":"IF Azmi","year":"2008","unstructured":"Azmi, I. F. et al. ESCRT-III family members stimulate Vps4 ATPase activity directly or via Vta1. Dev. Cell 14, 50\u201361 (2008).","journal-title":"Dev. Cell"},{"key":"59504_CR24","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41417-020-0200-0","volume":"28","author":"J Liu","year":"2021","unstructured":"Liu, J., Kang, R. & Tang, D. ESCRT-III-mediated membrane repair in cell death and tumor resistance. Cancer Gene Ther. 28, 1\u20134 (2021).","journal-title":"Cancer Gene Ther."},{"key":"59504_CR25","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1038\/s41580-019-0177-4","volume":"21","author":"M Vietri","year":"2020","unstructured":"Vietri, M., Radulovic, M. & Stenmark, H. The many functions of ESCRTs. Nat. Rev. Mol. Cell Biol. 21, 25\u201342 (2020).","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"59504_CR26","doi-asserted-by":"publisher","first-page":"1283","DOI":"10.1084\/jem.20150407","volume":"212","author":"MB Greenblatt","year":"2015","unstructured":"Greenblatt, M. B. et al. CHMP5 controls bone turnover rates by dampening NF-\u03baB activity in osteoclasts. J. Exp. Med. 212, 1283\u20131301 (2015).","journal-title":"J. Exp. Med."},{"key":"59504_CR27","doi-asserted-by":"publisher","first-page":"780","DOI":"10.1038\/ni.3764","volume":"18","author":"S Adoro","year":"2017","unstructured":"Adoro, S. et al. Post-translational control of T cell development by the ESCRT protein CHMP5. Nat. Immunol. 18, 780\u2013790 (2017).","journal-title":"Nat. Immunol."},{"key":"59504_CR28","doi-asserted-by":"publisher","first-page":"494","DOI":"10.1038\/nrc.2016.63","volume":"16","author":"L Belver","year":"2016","unstructured":"Belver, L. & Ferrando, A. The genetics and mechanisms of T cell acute lymphoblastic leukaemia. Nat. Rev. Cancer 16, 494\u2013507 (2016).","journal-title":"Nat. Rev. Cancer"},{"key":"59504_CR29","doi-asserted-by":"publisher","first-page":"1279","DOI":"10.1038\/sj.leu.2404258","volume":"20","author":"T Palomero","year":"2006","unstructured":"Palomero, T. et al. CUTLL1, a novel human T-cell lymphoma cell line with t(7;9) rearrangement, aberrant NOTCH1 activation and high sensitivity to gamma-secretase inhibitors. Leukemia 20, 1279\u20131287 (2006).","journal-title":"Leukemia"},{"key":"59504_CR30","doi-asserted-by":"publisher","first-page":"12889","DOI":"10.1073\/pnas.1005938107","volume":"107","author":"E Morita","year":"2010","unstructured":"Morita, E. et al. Human ESCRT-III and VPS4 proteins are required for centrosome and spindle maintenance. Proc. Natl Acad. Sci. USA 107, 12889\u201312894 (2010).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"59504_CR31","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1038\/sj.onc.1208997","volume":"25","author":"YH Kim","year":"2006","unstructured":"Kim, Y. H. et al. Combined microarray analysis of small cell lung cancer reveals altered apoptotic balance and distinct expression signatures of MYC family gene amplification. Oncogene 25, 130\u2013138 (2006).","journal-title":"Oncogene"},{"key":"59504_CR32","doi-asserted-by":"publisher","first-page":"1045","DOI":"10.1083\/jcb.200509041","volume":"172","author":"JH Shim","year":"2006","unstructured":"Shim, J. H. et al. CHMP5 is essential for late endosome function and down-regulation of receptor signaling during mouse embryogenesis. J. Cell Biol. 172, 1045\u20131056 (2006).","journal-title":"J. Cell Biol."},{"key":"59504_CR33","doi-asserted-by":"crossref","unstructured":"Gabay, M., Li, Y. & Felsher, D. W. MYC activation is a hallmark of cancer initiation and maintenance. Cold Spring Harb Perspect Med 4, a014241 (2014).","DOI":"10.1101\/cshperspect.a014241"},{"key":"59504_CR34","doi-asserted-by":"publisher","DOI":"10.1186\/s12964-021-00741-y","volume":"19","author":"J Lu","year":"2021","unstructured":"Lu, J. et al. Types of nuclear localization signals and mechanisms of protein import into the nucleus. Cell Commun. Signal. 19, 60 (2021).","journal-title":"Cell Commun. Signal."},{"key":"59504_CR35","doi-asserted-by":"publisher","first-page":"43910","DOI":"10.1074\/jbc.M112.417899","volume":"287","author":"JJ Skalicky","year":"2012","unstructured":"Skalicky, J. J. et al. Interactions of the human LIP5 regulatory protein with endosomal sorting complexes required for transport. J. Biol. Chem. 287, 43910\u201343926 (2012).","journal-title":"J. Biol. Chem."},{"key":"59504_CR36","doi-asserted-by":"publisher","first-page":"1067","DOI":"10.1038\/nature09504","volume":"468","author":"P Filippakopoulos","year":"2010","unstructured":"Filippakopoulos, P. et al. Selective inhibition of BET bromodomains. Nature 468, 1067\u20131073 (2010).","journal-title":"Nature"},{"key":"59504_CR37","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1016\/j.molcel.2005.06.029","volume":"19","author":"Z Yang","year":"2005","unstructured":"Yang, Z. et al. Recruitment of P-TEFb for stimulation of transcriptional elongation by the bromodomain protein Brd4. Mol. Cell 19, 535\u2013545 (2005).","journal-title":"Mol. Cell"},{"key":"59504_CR38","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1016\/j.molcel.2017.06.004","volume":"67","author":"GE Winter","year":"2017","unstructured":"Winter, G. E. et al. BET bromodomain proteins function as master transcription elongation factors independent of CDK9 recruitment. Mol. Cell 67, 5\u201318.e19 (2017).","journal-title":"Mol. Cell"},{"key":"59504_CR39","doi-asserted-by":"publisher","first-page":"1047","DOI":"10.1038\/nsmb.2912","volume":"21","author":"T Kanno","year":"2014","unstructured":"Kanno, T. et al. BRD4 assists elongation of both coding and enhancer RNAs by interacting with acetylated histones. Nat. Struct. Mol. Biol. 21, 1047\u20131057 (2014).","journal-title":"Nat. Struct. Mol. Biol."},{"key":"59504_CR40","doi-asserted-by":"publisher","first-page":"1512","DOI":"10.1038\/ng.2007.26","volume":"39","author":"J Zeitlinger","year":"2007","unstructured":"Zeitlinger, J. et al. RNA polymerase stalling at developmental control genes in the Drosophila melanogaster embryo. Nat. Genet. 39, 1512\u20131516 (2007).","journal-title":"Nat. Genet."},{"key":"59504_CR41","doi-asserted-by":"publisher","first-page":"705","DOI":"10.1073\/pnas.1315023111","volume":"111","author":"H Wang","year":"2014","unstructured":"Wang, H. et al. NOTCH1\u2013RBPJ complexes drive target gene expression through dynamic interactions with superenhancers. Proc. Natl Acad. Sci. 111, 705\u2013710 (2014).","journal-title":"Proc. Natl Acad. Sci."},{"key":"59504_CR42","doi-asserted-by":"publisher","first-page":"432","DOI":"10.1016\/j.cell.2010.03.030","volume":"141","author":"PB Rahl","year":"2010","unstructured":"Rahl, P. B. et al. c-Myc regulates transcriptional pause release. Cell 141, 432\u2013445 (2010).","journal-title":"Cell"},{"key":"59504_CR43","doi-asserted-by":"publisher","first-page":"186","DOI":"10.1038\/nature08449","volume":"461","author":"NJ Fuda","year":"2009","unstructured":"Fuda, N. J., Ardehali, M. B. & Lis, J. T. Defining mechanisms that regulate RNA polymerase II transcription in vivo. Nature 461, 186\u2013192 (2009).","journal-title":"Nature"},{"key":"59504_CR44","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1016\/j.cell.2013.03.035","volume":"153","author":"WA Whyte","year":"2013","unstructured":"Whyte, W. A. et al. Master transcription factors and mediator establish super-enhancers at key cell identity genes. Cell 153, 307\u2013319 (2013).","journal-title":"Cell"},{"key":"59504_CR45","doi-asserted-by":"publisher","first-page":"934","DOI":"10.1016\/j.cell.2013.09.053","volume":"155","author":"D Hnisz","year":"2013","unstructured":"Hnisz, D. et al. Super-enhancers in the control of cell identity and disease. Cell 155, 934\u2013947 (2013).","journal-title":"Cell"},{"key":"59504_CR46","doi-asserted-by":"publisher","first-page":"1028","DOI":"10.1016\/j.molcel.2015.04.011","volume":"58","author":"JS Roe","year":"2015","unstructured":"Roe, J. S., Mercan, F., Rivera, K., Pappin, D. J. & Vakoc, C. R. BET bromodomain inhibition suppresses the function of hematopoietic transcription factors in acute myeloid leukemia. Mol. Cell 58, 1028\u20131039 (2015).","journal-title":"Mol. Cell"},{"key":"59504_CR47","doi-asserted-by":"publisher","first-page":"1756","DOI":"10.1016\/j.celrep.2018.10.003","volume":"25","author":"T Wu","year":"2018","unstructured":"Wu, T., Kamikawa, Y. F. & Donohoe, M. E. Brd4\u2019s bromodomains mediate histone H3 acetylation and chromatin remodeling in pluripotent cells through P300 and Brg1. Cell Rep. 25, 1756\u20131771 (2018).","journal-title":"Cell Rep."},{"key":"59504_CR48","doi-asserted-by":"crossref","unstructured":"Sanders, Y. Y. et al. Brd4-p300 inhibition downregulates Nox4 and accelerates lung fibrosis resolution in aged mice. JCI Insight 5, e137127 (2020).","DOI":"10.1172\/jci.insight.137127"},{"key":"59504_CR49","doi-asserted-by":"publisher","first-page":"1770","DOI":"10.1021\/acschembio.5b00216","volume":"10","author":"M Zengerle","year":"2015","unstructured":"Zengerle, M., Chan, K. H. & Ciulli, A. Selective small molecule induced degradation of the BET bromodomain protein BRD4. ACS Chem. Biol. 10, 1770\u20131777 (2015).","journal-title":"ACS Chem. Biol."},{"key":"59504_CR50","doi-asserted-by":"publisher","first-page":"1118","DOI":"10.1158\/2159-8290.CD-20-0751","volume":"11","author":"J Welti","year":"2021","unstructured":"Welti, J. et al. Targeting the p300\/CBP axis in lethal prostate cancer. Cancer Discov. 11, 1118\u20131137 (2021).","journal-title":"Cancer Discov."},{"key":"59504_CR51","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1038\/nature24028","volume":"550","author":"LM Lasko","year":"2017","unstructured":"Lasko, L. M. et al. Discovery of a selective catalytic p300\/CBP inhibitor that targets lineage-specific tumours. Nature 550, 128\u2013132 (2017).","journal-title":"Nature"},{"key":"59504_CR52","doi-asserted-by":"publisher","first-page":"4124","DOI":"10.1182\/bloodadvances.2020001879","volume":"4","author":"F Spriano","year":"2020","unstructured":"Spriano, F. et al. Antitumor activity of the dual BET and CBP\/EP300 inhibitor NEO2734. Blood Adv. 4, 4124\u20134135 (2020).","journal-title":"Blood Adv."},{"key":"59504_CR53","doi-asserted-by":"publisher","DOI":"10.15252\/emmm.201910659","volume":"11","author":"Y Yan","year":"2019","unstructured":"Yan, Y. et al. The novel BET-CBP\/p300 dual inhibitor NEO2734 is active in SPOP mutant and wild-type prostate cancer. EMBO Mol. Med. 11, e10659 (2019).","journal-title":"EMBO Mol. Med."},{"key":"59504_CR54","doi-asserted-by":"publisher","first-page":"2571","DOI":"10.1084\/jem.20112239","volume":"208","author":"P Van Vlierberghe","year":"2011","unstructured":"Van Vlierberghe, P. et al. ETV6 mutations in early immature human T cell leukemias. J. Exp. Med 208, 2571\u20132579 (2011).","journal-title":"J. Exp. Med"},{"key":"59504_CR55","doi-asserted-by":"publisher","first-page":"1157","DOI":"10.1038\/s41591-018-0105-8","volume":"24","author":"N Kourtis","year":"2018","unstructured":"Kourtis, N. et al. Oncogenic hijacking of the stress response machinery in T cell acute lymphoblastic leukemia. Nat. Med. 24, 1157\u20131166 (2018).","journal-title":"Nat. Med."},{"key":"59504_CR56","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1182\/asheducation.V2012.1.389.3798360","volume":"2012","author":"CG Mullighan","year":"2012","unstructured":"Mullighan, C. G. The molecular genetic makeup of acute lymphoblastic leukemia. Hematol. Am. Soc. Hematol. Educ. Program 2012, 389\u2013396 (2012).","journal-title":"Hematol. Am. Soc. Hematol. Educ. Program"},{"key":"59504_CR57","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1073\/pnas.1717125115","volume":"115","author":"B Chen","year":"2018","unstructured":"Chen, B. et al. Identification of fusion genes and characterization of transcriptome features in T-cell acute lymphoblastic leukemia. Proc. Natl Acad. Sci. 115, 373\u2013378 (2018).","journal-title":"Proc. Natl Acad. Sci."},{"key":"59504_CR58","doi-asserted-by":"publisher","first-page":"547","DOI":"10.1200\/JCO.2000.18.3.547","volume":"18","author":"HM Kantarjian","year":"2000","unstructured":"Kantarjian, H. M. et al. Results of treatment with hyper-CVAD, a dose-intensive regimen, in adult acute lymphocytic leukemia. J. Clin. Oncol. 18, 547\u2013547 (2000).","journal-title":"J. Clin. Oncol."},{"key":"59504_CR59","doi-asserted-by":"publisher","first-page":"833","DOI":"10.1182\/blood-2014-10-551895","volume":"126","author":"MR Litzow","year":"2015","unstructured":"Litzow, M. R. & Ferrando, A. A. How I treat T-cell acute lymphoblastic leukemia in adults. Blood 126, 833\u2013841 (2015).","journal-title":"Blood"},{"key":"59504_CR60","doi-asserted-by":"crossref","unstructured":"Habets, R. A. et al. Safe targeting of T cell acute lymphoblastic leukemia by pathology-specific NOTCH inhibition. Sci. Transl. Med. 11, eaau6246 (2019).","DOI":"10.1126\/scitranslmed.aau6246"},{"key":"59504_CR61","doi-asserted-by":"publisher","DOI":"10.1038\/bcj.2015.80","volume":"5","author":"C Papayannidis","year":"2015","unstructured":"Papayannidis, C. et al. A Phase 1 study of the novel gamma-secretase inhibitor PF-03084014 in patients with T-cell acute lymphoblastic leukemia and T-cell lymphoblastic lymphoma. Blood Cancer J. 5, e350 (2015).","journal-title":"Blood Cancer J."},{"key":"59504_CR62","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1038\/nm.1900","volume":"15","author":"PJ Real","year":"2009","unstructured":"Real, P. J. et al. Gamma-secretase inhibitors reverse glucocorticoid resistance in T cell acute lymphoblastic leukemia. Nat. Med. 15, 50\u201358 (2009).","journal-title":"Nat. Med."},{"key":"59504_CR63","doi-asserted-by":"publisher","first-page":"2283","DOI":"10.1084\/jem.183.5.2283","volume":"183","author":"WS Pear","year":"1996","unstructured":"Pear, W. S. et al. Exclusive development of T cell neoplasms in mice transplanted with bone marrow expressing activated Notch alleles. J. Exp. Med 183, 2283\u20132291 (1996).","journal-title":"J. Exp. Med"},{"key":"59504_CR64","doi-asserted-by":"publisher","first-page":"342","DOI":"10.1002\/eji.200737972","volume":"38","author":"CY Huang","year":"2008","unstructured":"Huang, C. Y., Bredemeyer, A. L., Walker, L. M., Bassing, C. H. & Sleckman, B. P. Dynamic regulation of c-Myc proto-oncogene expression during lymphocyte development revealed by a GFP-c-Myc knock-in mouse. Eur. J. Immunol. 38, 342\u2013349 (2008).","journal-title":"Eur. J. Immunol."},{"key":"59504_CR65","doi-asserted-by":"publisher","first-page":"1989","DOI":"10.1182\/blood-2010-11-319129","volume":"118","author":"K Niessen","year":"2011","unstructured":"Niessen, K. et al. The Notch1-Dll4 signaling pathway regulates mouse postnatal lymphatic development. Blood 118, 1989\u20131997 (2011).","journal-title":"Blood"},{"key":"59504_CR66","doi-asserted-by":"publisher","first-page":"1249","DOI":"10.1038\/leu.2011.93","volume":"25","author":"B Gerby","year":"2011","unstructured":"Gerby, B. et al. Expression of CD34 and CD7 on human T-cell acute lymphoblastic leukemia discriminates functionally heterogeneous cell populations. Leukemia 25, 1249\u20131258 (2011).","journal-title":"Leukemia"},{"key":"59504_CR67","doi-asserted-by":"publisher","first-page":"E8900","DOI":"10.1073\/pnas.1805504115","volume":"115","author":"JBA Sadler","year":"2018","unstructured":"Sadler, J. B. A. et al. A cancer-associated polymorphism in ESCRT-III disrupts the abscission checkpoint and promotes genome instability. Proc. Natl Acad. Sci. USA 115, E8900\u2013e8908 (2018).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"59504_CR68","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1016\/j.bbrc.2019.11.110","volume":"522","author":"E Dai","year":"2020","unstructured":"Dai, E., Meng, L., Kang, R., Wang, X. & Tang, D. ESCRT-III-dependent membrane repair blocks ferroptosis. Biochem. Biophys. Res Commun. 522, 415\u2013421 (2020).","journal-title":"Biochem. Biophys. Res Commun."},{"key":"59504_CR69","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2020.108493","volume":"33","author":"JE Neggers","year":"2020","unstructured":"Neggers, J. E. et al. Synthetic Lethal Interaction between the ESCRT Paralog Enzymes VPS4A and VPS4B in Cancers Harboring Loss of Chromosome 18q or 16q. Cell Rep. 33, 108493 (2020).","journal-title":"Cell Rep."},{"key":"59504_CR70","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1126\/science.abl3855","volume":"376","author":"AT Ritter","year":"2022","unstructured":"Ritter, A. T. et al. ESCRT-mediated membrane repair protects tumor-derived cells against T cell attack. Science 376, 377\u2013382 (2022).","journal-title":"Science"},{"key":"59504_CR71","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1016\/j.ygeno.2006.04.003","volume":"88","author":"HTH Tsang","year":"2006","unstructured":"Tsang, H. T. H. et al. A systematic analysis of human CHMP protein interactions: Additional MIT domain-containing proteins bind to multiple components of the human ESCRT III complex. Genomics 88, 333\u2013346 (2006).","journal-title":"Genomics"},{"key":"59504_CR72","doi-asserted-by":"publisher","first-page":"2635","DOI":"10.1016\/j.cub.2016.07.039","volume":"26","author":"Y Olmos","year":"2016","unstructured":"Olmos, Y., Perdrix-Rosell, A. & Carlton, J. G. Membrane binding by CHMP7 coordinates ESCRT-III-dependent nuclear envelope reformation. Curr. Biol. 26, 2635\u20132641 (2016).","journal-title":"Curr. Biol."},{"key":"59504_CR73","doi-asserted-by":"publisher","DOI":"10.1038\/s41389-019-0136-0","volume":"8","author":"J Willan","year":"2019","unstructured":"Willan, J. et al. ESCRT-III is necessary for the integrity of the nuclear envelope in micronuclei but is aberrant at ruptured micronuclear envelopes generating damage. Oncogenesis 8, 29 (2019).","journal-title":"Oncogenesis"},{"key":"59504_CR74","doi-asserted-by":"publisher","DOI":"10.1083\/jcb.201905091","volume":"219","author":"B Warecki","year":"2020","unstructured":"Warecki, B., Ling, X., Bast, I. & Sullivan, W. ESCRT-III\u2013mediated membrane fusion drives chromosome fragments through nuclear envelope channels. J. Cell Biol. 219, e201905091 (2020).","journal-title":"J. Cell Biol."},{"key":"59504_CR75","doi-asserted-by":"publisher","first-page":"2383","DOI":"10.1242\/jcs.114.13.2383","volume":"114","author":"DR Stauffer","year":"2001","unstructured":"Stauffer, D. R., Howard, T. L., Nyun, T. & Hollenberg, S. M. CHMP1 is a novel nuclear matrix protein affecting chromatin structure and cell-cycle progression. J. Cell Sci. 114, 2383\u20132393 (2001).","journal-title":"J. Cell Sci."},{"key":"59504_CR76","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1038\/onc.2015.92","volume":"35","author":"G Giotopoulos","year":"2016","unstructured":"Giotopoulos, G. et al. The epigenetic regulators CBP and p300 facilitate leukemogenesis and represent therapeutic targets in acute myeloid leukemia. Oncogene 35, 279\u2013289 (2016).","journal-title":"Oncogene"},{"key":"59504_CR77","doi-asserted-by":"publisher","first-page":"e55481","DOI":"10.1371\/journal.pone.0055481","volume":"8","author":"XN Gao","year":"2013","unstructured":"Gao, X. N. et al. A histone acetyltransferase p300 inhibitor C646 induces cell cycle arrest and apoptosis selectively in AML1-ETO-positive AML cells. PLoS ONE 8, e55481 (2013).","journal-title":"PLoS ONE"},{"key":"59504_CR78","doi-asserted-by":"publisher","first-page":"5106","DOI":"10.1158\/0008-5472.CAN-15-0236","volume":"75","author":"S Picaud","year":"2015","unstructured":"Picaud, S. et al. Generation of a selective small molecule inhibitor of the CBP\/p300 bromodomain for leukemia therapy. Cancer Res 75, 5106\u20135119 (2015).","journal-title":"Cancer Res"},{"key":"59504_CR79","doi-asserted-by":"publisher","first-page":"13457","DOI":"10.1073\/pnas.1919507117","volume":"117","author":"BN Devaiah","year":"2020","unstructured":"Devaiah, B. N. et al. MYC protein stability is negatively regulated by BRD4. Proc. Natl Acad. Sci. 117, 13457\u201313467 (2020).","journal-title":"Proc. Natl Acad. Sci."},{"key":"59504_CR80","doi-asserted-by":"publisher","first-page":"1522","DOI":"10.1210\/me.2014-1130","volume":"28","author":"MJ Guertin","year":"2014","unstructured":"Guertin, M. J., Zhang, X., Coonrod, S. A. & Hager, G. L. Transient estrogen receptor binding and p300 redistribution support a squelching mechanism for estradiol-repressed genes. Mol. Endocrinol. 28, 1522\u20131533 (2014).","journal-title":"Mol. Endocrinol."},{"key":"59504_CR81","doi-asserted-by":"publisher","first-page":"2183","DOI":"10.1016\/j.molcel.2021.04.015","volume":"81","author":"SJ Hogg","year":"2021","unstructured":"Hogg, S. J. et al. Targeting histone acetylation dynamics and oncogenic transcription by catalytic P300\/CBP inhibition. Mol. Cell 81, 2183\u20132200.e2113 (2021).","journal-title":"Mol. Cell"},{"key":"59504_CR82","doi-asserted-by":"publisher","first-page":"2877","DOI":"10.2147\/IJGM.S350228","volume":"15","author":"Y Guo","year":"2022","unstructured":"Guo, Y., Shang, A., Wang, S. & Wang, M. Multidimensional analysis of CHMP Family Members in Hepatocellular Carcinoma. Int. J. Gen. Med. 15, 2877\u20132894 (2022).","journal-title":"Int. J. Gen. Med."},{"key":"59504_CR83","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1093\/abbs\/gmt028","volume":"45","author":"H Wang","year":"2013","unstructured":"Wang, H. et al. The role of charged multivesicular body protein 5 in programmed cell death in leukemic cells. Acta Biochim. Biophys. Sin. 45, 383\u2013390 (2013).","journal-title":"Acta Biochim. Biophys. Sin."},{"key":"59504_CR84","doi-asserted-by":"publisher","first-page":"809","DOI":"10.1038\/aps.2012.38","volume":"33","author":"HR Wang","year":"2012","unstructured":"Wang, H. R. et al. Anti-CHMP5 single chain variable fragment antibody retrovirus infection induces programmed cell death of AML leukemic cells in vitro. Acta Pharm. Sin. 33, 809\u2013816 (2012).","journal-title":"Acta Pharm. Sin."},{"key":"59504_CR85","doi-asserted-by":"publisher","first-page":"763","DOI":"10.1016\/S1074-7613(01)00227-8","volume":"15","author":"PP Lee","year":"2001","unstructured":"Lee, P. P. et al. A critical role for Dnmt1 and DNA methylation in T cell development, function, and survival. Immunity 15, 763\u2013774 (2001).","journal-title":"Immunity"},{"key":"59504_CR86","doi-asserted-by":"publisher","first-page":"6509","DOI":"10.1128\/MCB.22.18.6509-6520.2002","volume":"22","author":"T Maruyama","year":"2002","unstructured":"Maruyama, T. et al. A Mammalian bromodomain protein, brd4, interacts with replication factor C and inhibits progression to S phase. Mol. Cell Biol. 22, 6509\u20136520 (2002).","journal-title":"Mol. Cell Biol."},{"key":"59504_CR87","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1093\/bioinformatics\/bts635","volume":"29","author":"A Dobin","year":"2012","unstructured":"Dobin, A. et al. STAR: ultrafast universal RNA-seq aligner. Bioinformatics 29, 15\u201321 (2012).","journal-title":"Bioinformatics"},{"key":"59504_CR88","doi-asserted-by":"publisher","first-page":"166","DOI":"10.1093\/bioinformatics\/btu638","volume":"31","author":"S Anders","year":"2015","unstructured":"Anders, S., Pyl, P. T. & Huber, W. HTSeq\u2013a Python framework to work with high-throughput sequencing data. Bioinformatics 31, 166\u2013169 (2015).","journal-title":"Bioinformatics"},{"key":"59504_CR89","doi-asserted-by":"publisher","DOI":"10.1186\/s13059-014-0550-8","volume":"15","author":"MI Love","year":"2014","unstructured":"Love, M. I., Huber, W. & Anders, S. Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2. Genome Biol. 15, 550 (2014).","journal-title":"Genome Biol."},{"key":"59504_CR90","doi-asserted-by":"publisher","first-page":"15545","DOI":"10.1073\/pnas.0506580102","volume":"102","author":"A Subramanian","year":"2005","unstructured":"Subramanian, A. et al. Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles. Proc. Natl Acad. Sci. USA 102, 15545\u201315550 (2005).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"59504_CR91","doi-asserted-by":"publisher","first-page":"1739","DOI":"10.1093\/bioinformatics\/btr260","volume":"27","author":"A Liberzon","year":"2011","unstructured":"Liberzon, A. et al. Molecular signatures database (MSigDB) 3.0. Bioinformatics 27, 1739\u20131740 (2011).","journal-title":"Bioinformatics"},{"key":"59504_CR92","doi-asserted-by":"publisher","first-page":"1184","DOI":"10.1038\/nprot.2009.97","volume":"4","author":"S Durinck","year":"2009","unstructured":"Durinck, S., Spellman, P. T., Birney, E. & Huber, W. Mapping identifiers for the integration of genomic datasets with the R\/Bioconductor package biomaRt. Nat. Protoc. 4, 1184\u20131191 (2009).","journal-title":"Nat. Protoc."},{"key":"59504_CR93","doi-asserted-by":"publisher","first-page":"D988","DOI":"10.1093\/nar\/gkab1049","volume":"50","author":"F Cunningham","year":"2021","unstructured":"Cunningham, F. et al. Ensembl 2022. Nucleic Acids Res. 50, D988\u2013D995 (2021).","journal-title":"Nucleic Acids Res."},{"key":"59504_CR94","doi-asserted-by":"publisher","first-page":"2032","DOI":"10.1093\/bioinformatics\/btv098","volume":"31","author":"A Tarasov","year":"2015","unstructured":"Tarasov, A., Vilella, A. J., Cuppen, E., Nijman, I. J. & Prins, P. Sambamba: fast processing of NGS alignment formats. Bioinformatics 31, 2032\u20132034 (2015).","journal-title":"Bioinformatics"},{"key":"59504_CR95","doi-asserted-by":"publisher","DOI":"10.1186\/gb-2008-9-9-r137","volume":"9","author":"Y Zhang","year":"2008","unstructured":"Zhang, Y. et al. Model-based analysis of ChIP-Seq (MACS). Genome Biol. 9, R137 (2008).","journal-title":"Genome Biol."},{"key":"59504_CR96","doi-asserted-by":"publisher","first-page":"2382","DOI":"10.1093\/bioinformatics\/btv145","volume":"31","author":"G Yu","year":"2015","unstructured":"Yu, G., Wang, L. G. & He, Q. Y. ChIPseeker: an R\/Bioconductor package for ChIP peak annotation, comparison and visualization. Bioinformatics 31, 2382\u20132383 (2015).","journal-title":"Bioinformatics"},{"key":"59504_CR97","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2164-15-284","volume":"15","author":"L Shen","year":"2014","unstructured":"Shen, L., Shao, N., Liu, X. & Nestler, E. ngs.plot: Quick mining and visualization of next-generation sequencing data by integrating genomic databases. BMC Genomics 15, 284 (2014).","journal-title":"BMC Genomics"},{"key":"59504_CR98","doi-asserted-by":"publisher","first-page":"320","DOI":"10.1016\/j.cell.2013.03.036","volume":"153","author":"J Lov\u00e9n","year":"2013","unstructured":"Lov\u00e9n, J. et al. Selective inhibition of tumor oncogenes by disruption of super-enhancers. Cell 153, 320\u2013334 (2013).","journal-title":"Cell"},{"key":"59504_CR99","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-017-00405-x","volume":"8","author":"J Chen","year":"2017","unstructured":"Chen, J. et al. VEGF amplifies transcription through ETS1 acetylation to enable angiogenesis. Nat. Commun. 8, 383 (2017).","journal-title":"Nat. Commun."},{"key":"59504_CR100","unstructured":"Team, R. C. R: A Language and Environment for Statistical Computing (R Foundation for Statistical Computing, 2022)."}],"container-title":["Nature Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41467-025-59504-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-025-59504-9","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-025-59504-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,3]],"date-time":"2025-05-03T16:04:10Z","timestamp":1746288250000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41467-025-59504-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5,3]]},"references-count":100,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["59504"],"URL":"https:\/\/doi.org\/10.1038\/s41467-025-59504-9","relation":{},"ISSN":["2041-1723"],"issn-type":[{"value":"2041-1723","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,5,3]]},"assertion":[{"value":"23 February 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 April 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 May 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"4133"}}